Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Expands By 766.7%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a significant increase in short interest in August. As of August 15th, there was short interest totalling 2,600 shares, an increase of 766.7% from the July 31st total of 300 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 0.4 days.

Lexaria Bioscience Stock Up 2.6 %

NASDAQ:LEXXW opened at $1.17 on Wednesday. Lexaria Bioscience has a 12 month low of $0.05 and a 12 month high of $2.50. The company has a 50-day moving average price of $1.17 and a 200-day moving average price of $1.17.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.